Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0100
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial ; volume:77 ; number:2 ; day:25 ; month:6 ; year:2022 ; pages:340-348 ; date:8.2022
Endocrine ; 77, Heft 2 (25.6.2022), 340-348, 8.2022
- Urheber
-
Marina, Michela
Maglietta, Giuseppe
Filpo, Giuseppina De
Aloe, Rosalia
Gnocchi, Cecilia
Iezzi, Elisa
Caminiti, Caterina
Ceresini, Graziano
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12020-022-03110-y
- URN
-
urn:nbn:de:101:1-2022100720353550994362
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Marina, Michela
- Maglietta, Giuseppe
- Filpo, Giuseppina De
- Aloe, Rosalia
- Gnocchi, Cecilia
- Iezzi, Elisa
- Caminiti, Caterina
- Ceresini, Graziano
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Thyroid Peroxidase Antibodies in Non-Autoimmune Hyperthyroidism Treated with Radioactive Iodine
Reduction of thyroid radioactive iodine exposure by oral administration of cyclic oligosaccharides
Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Thyroid Peroxidase Antibodies in Non-Autoimmune Hyperthyroidism Treated with Radioactive Iodine
Reduction of thyroid radioactive iodine exposure by oral administration of cyclic oligosaccharides
Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Thyroid Peroxidase Antibodies in Non-Autoimmune Hyperthyroidism Treated with Radioactive Iodine
Reduction of thyroid radioactive iodine exposure by oral administration of cyclic oligosaccharides
Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm